Kenvue Inc. (NYSE:KVUE) Shares Bought by Transcend Capital Advisors LLC

Transcend Capital Advisors LLC boosted its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 35.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 84,816 shares of the company’s stock after acquiring an additional 22,058 shares during the quarter. Transcend Capital Advisors LLC’s holdings in Kenvue were worth $1,826,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Beaumont Financial Advisors LLC increased its stake in Kenvue by 3.0% during the fourth quarter. Beaumont Financial Advisors LLC now owns 17,532 shares of the company’s stock worth $377,000 after acquiring an additional 509 shares during the last quarter. Pinnacle Bancorp Inc. boosted its position in shares of Kenvue by 51.3% during the fourth quarter. Pinnacle Bancorp Inc. now owns 1,552 shares of the company’s stock worth $33,000 after buying an additional 526 shares during the period. Dfpg Investments LLC boosted its position in shares of Kenvue by 2.3% during the fourth quarter. Dfpg Investments LLC now owns 26,659 shares of the company’s stock worth $567,000 after buying an additional 589 shares during the period. Mutual Advisors LLC boosted its position in shares of Kenvue by 6.1% during the fourth quarter. Mutual Advisors LLC now owns 10,606 shares of the company’s stock worth $228,000 after buying an additional 612 shares during the period. Finally, Baron Wealth Management LLC boosted its position in shares of Kenvue by 7.5% during the fourth quarter. Baron Wealth Management LLC now owns 12,915 shares of the company’s stock worth $278,000 after buying an additional 899 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on KVUE. Sanford C. Bernstein began coverage on Kenvue in a research report on Thursday, April 11th. They set an “underperform” rating and a $18.00 price target for the company. Royal Bank of Canada lowered their price target on Kenvue from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, February 9th. William Blair initiated coverage on Kenvue in a research report on Wednesday, April 3rd. They set a “market perform” rating for the company. JPMorgan Chase & Co. decreased their target price on Kenvue from $25.00 to $24.00 and set an “overweight” rating for the company in a report on Friday, February 9th. Finally, The Goldman Sachs Group initiated coverage on Kenvue in a report on Friday, March 1st. They issued a “neutral” rating and a $20.00 target price for the company. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, Kenvue has an average rating of “Hold” and an average target price of $24.85.

Kenvue Price Performance

Kenvue stock traded down $0.16 during midday trading on Friday, reaching $18.86. The company’s stock had a trading volume of 15,454,689 shares, compared to its average volume of 13,458,618. The business has a 50-day simple moving average of $19.84 and a 200-day simple moving average of $20.13. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 0.69. Kenvue Inc. has a fifty-two week low of $17.82 and a fifty-two week high of $27.80.

Kenvue (NYSE:KVUE) last posted its earnings results on Thursday, February 8th. The company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.03. Kenvue had a return on equity of 15.62% and a net margin of 9.87%. The business had revenue of $3.67 billion for the quarter, compared to analysts’ expectations of $3.78 billion. The business’s revenue for the quarter was down 2.7% compared to the same quarter last year. On average, equities analysts predict that Kenvue Inc. will post 1.15 EPS for the current year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 22nd. Investors of record on Wednesday, May 8th will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 4.24%. The ex-dividend date is Tuesday, May 7th.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.